Verrica Pharmaceuticals Inc (NASDAQ:VRCA)
| 3.69 Delayed Data As of Nov 30 |  -0.22 / -5.63%Today’s Change | 2.33 Today|||52-Week Range 8.70 | +34.18% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | -- | |||
| Operating Activities | Net Income / Starting Line | -1.9M | -4.5M | -20.6M | -- | |
| Depreciation | -- | -- | 20.0K | -- | ||
| Total Other Cash Flow | 9.0K | 82.0K | 1.8M | -- | ||
| Funds From Operations | -1.9M | -4.4M | -18.8M | -- | ||
| Funds From/For Other Operating Expenses | -293.0K | 206.0K | -938.0K | -- | ||
| Net Cash Flow - Operating Activities | -1.6M | -4.6M | -17.9M | -- | ||
| Investing | Increase In Investments | -- | -- | -79.1M | -- | |
| Capital Expenditures | -- | -- | -275.0K | -- | ||
| Other Investing - Uses | 0.00 | 0.00 | -499.0K | -- | ||
| Net Cash Flow Investing | 0.00 | 0.00 | -79.9M | -- | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | -- | -- |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | -- | -- | |
| Long Term Debt Reduction | 0.00 | 0.00 | 0.00 | -- | -- | |
| Net Proceeds Stock Sale | 483.0K | 12.7M | 99.4M | -- | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | -- | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | -- | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | -- | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | -- | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | -- | -- | |
| Net Cash Flow - Financing | 483.0K | 12.7M | 99.4M | -- | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | -1.1M | 8.1M | 1.6M | -- | ||
